Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 14, Number 7—July 2008

CME ACTIVITY - Research

Alcaligenes xylosoxidans Bloodstream Infections in Outpatient Oncology Office

Moon J. Kim*Comments to Author , Elizabeth Bancroft*, Eleanor Lehnkering*, Rodney M. Donlan†, and Laurene Mascola*
Author affiliations: *Los Angeles County Department of Public Health, Los Angeles, California, USA; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA;

Main Article

Table

Characteristics of 12 case-patients with bacteremia caused by Alcaligenes xylosoxidans*

Case-patient no. Age, y Sex Underlying disease Date of CVC flush Date of onset, symptoms† Date of blood collection‡
Case–control study
1 70 F Acute myelogenous leukemia 2001 Nov 19 2001 Nov 19, rigors after flush 2001 Nov 19
2 65 F Breast cancer 2001 Dec 5 2001 Dec 5, no chart record of symptoms after flush, blood culture obtained next day 2001 Dec 6
3 73 F Colon cancer 2001 Dec 7 2001 Dec 7, fever after flush 2001 Dec 7
4 41 F Sickle cell disease 2001 Dec 4 2001 Dec 11, myalgias, emesis 2001 Dec 11
5 73 F Gastric cancer Unknown Unknown 2001 Dec 13
6 71 M Colon cancer 2001 Dec18 2001 Dec 19, fever, chills 2001 Dec 20
7 79 F Pancreatic cancer Unknown Unknown 2001 Dec 30
8 45 F Breast cancer 2002 Jan 10 2002 Jan 10, no chart record of symptoms after flush, blood culture obtained next day 2001 Jan 10
9
70
F
Non-Hodgkin lymphoma
2002 Jan 10
2002 Jan 10, hypotension after infusion
2002 Jan 11
Prospective study
10 77 F Squamous cell cancer of palate NA 2001 Nov/Dec, intermittent nausea and weakness 2002 Jan 29
11 77 M Gastric cancer NA 2001 Nov/Dec, intermittent fever, chills after flushes, not reported to Office B staff 2002 Feb 7
12 49 F Non-Hodgkin lymphoma NA Asymptomatic 2002 Feb 5

*CVC, central venous catheter; NA, not applicable.
†Signs and symptoms of bloodstream infection.
‡Collection of blood that had subsequent positive culture result for A. xylosoxidans.

Main Article

TOP